Holen Sie sich die Stockscreener-App
2.6372
2.98%
-0.0928
Schlusskurs vom Vortag:
$2.73
Offen:
$2.77
24-Stunden-Volumen:
246.14K
Relative Volume:
0.24
Marktkapitalisierung:
$196.05M
Einnahmen:
$6.96M
Nettoeinkommen (Verlust:
$-46.51M
KGV:
-15.37
EPS:
-0.1716
Netto-Cashflow:
$-37.99M
1W Leistung:
-14.56%
1M Leistung:
-27.24%
6M Leistung:
+3.46%
1J Leistung:
-78.09%
1-Tages-Spanne:
$2.63
$2.77
1-Wochen-Bereich:
$2.60
$3.10
52-Wochen-Spanne:
$1.60
$12.90
Perspective Therapeutics Inc Stock (CATX) Company Profile
Firmenname
Perspective Therapeutics Inc
Sektor
Branche
Telefon
509-375-1202
Adresse
350 Hills Street, Suite 106, Richland
Vergleichen Sie CATX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CATX
Perspective Therapeutics Inc
|
2.64 | 202.74M | 6.96M | -46.51M | -37.99M | -0.1716 |
|
ABT
Abbott Laboratories
|
122.72 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.27 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.14 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
80.34 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-10 | Eingeleitet | BTIG Research | Buy |
| 2025-03-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-11-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-01 | Eingeleitet | Wedbush | Outperform |
| 2024-09-25 | Eingeleitet | Truist | Buy |
| 2024-07-25 | Eingeleitet | BofA Securities | Buy |
| 2024-05-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten
Can Perspective Therapeutics Inc. stock hit record highs againJuly 2025 Volume & Verified High Yield Trade Plans - newser.com
What downside risks could hit Perspective Therapeutics Inc. (AAJ0) stockJuly 2025 Summary & Daily Price Action Insights - newser.com
Will Perspective Therapeutics Inc. stock split again soon2025 Winners & Losers & High Accuracy Investment Entry Signals - newser.com
Is Perspective Therapeutics Inc. stock a buy before product launches2025 Key Lessons & Free Real-Time Market Sentiment Alerts - newser.com
Can Perspective Therapeutics Inc. stock stage a strong rebound this quarterJuly 2025 Reactions & Daily Profit Focused Screening - newser.com
Tick level data insight on Perspective Therapeutics Inc. volatilityWeekly Market Report & Accurate Intraday Trading Signals - newser.com
Will Perspective Therapeutics Inc. stock benefit from infrastructure spendingSwing Trade & Expert Verified Stock Movement Alerts - newser.com
What margin trends mean for Perspective Therapeutics Inc. stockDay Trade & Free Weekly Watchlist of Top Performers - newser.com
Will Perspective Therapeutics Inc. stock see PE expansionJuly 2025 Sector Moves & High Win Rate Trade Tips - newser.com
Custom watchlist performance reports with Perspective Therapeutics Inc.July 2025 Spike Watch & Safe Entry Point Identification - newser.com
How to track smart money flows in Perspective Therapeutics Inc.2025 Price Momentum & Free Growth Oriented Trading Recommendations - newser.com
Can Perspective Therapeutics Inc. stock withstand sector downturnsMarket Performance Report & Weekly Breakout Opportunity Watchlist - newser.com
How Perspective Therapeutics Inc. stock reacts to inflationary pressuresQuarterly Earnings Summary & Capital Efficient Trading Techniques - newser.com
Analysts Are Bullish on These Healthcare Stocks: Bioxcel Therapeutics (BTAI), Perspective Therapeutics (CATX) - The Globe and Mail
Perspective Therapeutics to Engage with Investors at Upcoming Conferences - Quiver Quantitative
Perspective Therapeutics to Participate in Upcoming November Conferences - The Manila Times
How Perspective Therapeutics Inc. stock performs in interest rate cycles2025 Stock Rankings & Consistent Profit Alerts - newser.com
Perspective (NYSE AMERICAN: CATX) at Truist Nov 6, UBS fireside chat Nov 11 - Stock Titan
Identifying reversal signals in Perspective Therapeutics Inc.Weekly Gains Report & Precise Swing Trade Alerts - newser.com
Can Perspective Therapeutics Inc. recover in the next quarterQuarterly Growth Report & Expert Curated Trade Setups - newser.com
Can Perspective Therapeutics Inc. stock sustain margin levelsJuly 2025 Price Swings & Expert Verified Movement Alerts - newser.com
Order flow analysis tools used on Perspective Therapeutics Inc.Buy Signal & Accurate Buy Signal Notifications - newser.com
Analyzing recovery setups for Perspective Therapeutics Inc. investors2025 Momentum Check & Safe Capital Preservation Plans - newser.com
Will Perspective Therapeutics Inc. (AAJ0) stock profit from automation waveFed Meeting & Target Return Focused Stock Picks - newser.com
Perspective Therapeutics Advances Cancer Treatment with Innovative Clinical Study - TipRanks
How Perspective Therapeutics Inc. (AAJ0) stock valuation compares with sectorEarnings Growth Report & Safe Entry Zone Identification - newser.com
Perspective Therapeutics Inc. recovery potential after sell offQuarterly Market Summary & Risk Managed Investment Strategies - newser.com
Finanzdaten der Perspective Therapeutics Inc-Aktie (CATX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
0.27%
Kapitalisierung:
|
Volumen (24h):